SCHEMBL17635590

SCHEMBL17635590

Cc1ccc2c(c1)CCCN2CCC(=O)NCCN(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 10/20 0.50
▸ CHRM4 P08173 9/20 0.50
▸ CHRM1 P11229 9/20 0.50
▸ CHRM3 P20309 9/20 0.50
▸ KDM4E B2RXH2 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ GAA P10253 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HTT P42858 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CASP1 P29466 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2822089 0.86 ALDH1A1 (0.49) CHRM2CHRM4CHRM1CHRM3KDM4E
SCHEMBL2823023 0.85 CHRM2 (0.62) CHRM2CHRM4CHRM1CHRM3KDM4E
SCHEMBL25818515 0.81 ALDH1A1 (0.54) CHRM2CHRM4CHRM1CHRM3KDM4E
SCHEMBL25818505 0.73 ALDH1A1 (0.65) CHRM2CHRM4CHRM1CHRM3KDM4E
SCHEMBL14747436 0.72 CHRM2 (0.56) CHRM2CHRM4CHRM1CHRM3KDM4E
SCHEMBL14564422 0.71 CHRM2 (0.71) CHRM2CHRM4CHRM1CHRM3KDM4E
SCHEMBL14288519 0.70 CHRM2 (0.63) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL5905885 0.70 CHRM2 (0.56) CHRM2CHRM4CHRM1CHRM3KDM4E
SCHEMBL14564376 0.70 CHRM2 (0.67) CHRM2CHRM4CHRM1CHRM3KDM4E
SCHEMBL12656456 0.70 CHRM2 (0.70) CHRM2CHRM4CHRM1CHRM3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3001199-A1 AUTOPHAGY AND PHOSPHOLIPIDOSIS PATHWAY ASSAYS Enzo Life Sciences, Inc. (US) 2016-03-30 — — EP disclosed
Send feedback